The differential sensitivity of free and membrane-bound polyribosomes to inhibitors of protein synthesis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D002499:Centrifugation, Density Gradient; D002701:Chloramphenicol / Q000494:pharmacology; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004640:Emetine / Q000494:pharmacology; D005672:Fusidic Acid / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008566:Membranes / Q000187:drug effects / Q000378:metabolism; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D051381:Rats; D012270:Ribosomes / Q000187:drug effects* / Q000378:metabolism*; D014316:Tritium
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D003509:Cyclohexanecarboxylic Acids; D014316:Tritium; D011691:Puromycin; D005672:Fusidic Acid; D002701:Chloramphenicol; D003513:Cycloheximide; D007930:Leucine; D004640:Emetine